| 000 | 01579 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513215745.0 | ||
| 264 | 0 | _c20000830 | |
| 008 | 200008s 0 0 eng d | ||
| 022 | _a1052-2166 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCapes-Davis, A | |
| 245 | 0 | 0 |
_aGlucocorticoids differentially inhibit expression of the RET proto-oncogene. _h[electronic resource] |
| 260 |
_bGene expression _c1999 |
||
| 300 |
_a311-26 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aCarcinoma, Medullary _xgenetics |
| 650 | 0 | 4 | _aCell Division |
| 650 | 0 | 4 |
_aDexamethasone _xmetabolism |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrosophila Proteins |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 | _aGlial Cell Line-Derived Neurotrophic Factor Receptors |
| 650 | 0 | 4 |
_aGlucocorticoids _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPregnenediones _xpharmacology |
| 650 | 0 | 4 | _aProto-Oncogene Mas |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins _xdrug effects |
| 650 | 0 | 4 | _aProto-Oncogene Proteins c-ret |
| 650 | 0 | 4 |
_aReceptor Protein-Tyrosine Kinases _xdrug effects |
| 650 | 0 | 4 |
_aSteroids _xmetabolism |
| 650 | 0 | 4 |
_aThyroid Neoplasms _xgenetics |
| 650 | 0 | 4 | _aTranscription, Genetic |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aAndrew, S D | |
| 700 | 1 | _aHyland, V J | |
| 700 | 1 | _aTwigg, S | |
| 700 | 1 | _aLearoyd, D L | |
| 700 | 1 | _aDwight, T | |
| 700 | 1 | _aMarsh, D J | |
| 700 | 1 | _aRobinson, B G | |
| 773 | 0 |
_tGene expression _gvol. 8 _gno. 5-6 _gp. 311-26 |
|
| 999 |
_c10895791 _d10895791 |
||